Literature DB >> 25023235

[Management of complications after residual tumor resection for metastatic testicular cancer].

A Lusch1, M Zaum, C Winter, P Albers.   

Abstract

Residual tumor resection (RTR) in patients with metastatic testicular cancer plays a pivotal role in a multimodal treatment. It can be performed unilaterally or as an extended bilateral RTR. Additional surgical procedures might be necessary, such as nephrectomy, splenectomy, partial colectomy, or vascular interventions with possible caval resection, cavotomy, or aortic resection with aortic grafting. Consequently, several complications can be seen in the intra- and postoperative course, most common of which are superficial wound infections, intestinal paralysis, lymphocele, and chylous ascites. We sought to describe complication management and how to prevent complications before they arise.

Entities:  

Mesh:

Year:  2014        PMID: 25023235     DOI: 10.1007/s00120-014-3502-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  12 in total

1.  Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.

Authors:  Axel Heidenreich; Peter Albers; Michael Hartmann; Sabine Kliesch; Kai-Uwe Kohrmann; Susanne Krege; Philipp Lossin; Lothar Weissbach
Journal:  J Urol       Date:  2003-05       Impact factor: 7.450

2.  Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.

Authors:  Hooman Djaladat; Craig Nichols; Siamak Daneshmand
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

3.  The hazards of anesthesia and surgery in bleomycin-treated patients.

Authors:  P L Goldiner; O Schweizer
Journal:  Semin Oncol       Date:  1979-03       Impact factor: 4.929

Review 4.  The diagnosis and management of postoperative chylous ascites.

Authors:  Ilan Leibovitch; Yoram Mor; Jacob Golomb; Jacob Ramon
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

5.  Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node dissection.

Authors:  K Clint Cary; Stephen D W Beck; Richard Bihrle; Richard S Foster
Journal:  J Urol       Date:  2012-09-24       Impact factor: 7.450

6.  Repeat retroperitoneal lymphadenectomy in advanced testicular cancer.

Authors:  Axel Heidenreich; Carsten Ohlmann; Axel Hegele; Jörg Beyer
Journal:  Eur Urol       Date:  2005-01       Impact factor: 20.096

7.  Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor.

Authors:  Murilo A Luz; Ahmed F Kotb; Saad Aldousari; Fadi Brimo; Simon Tanguay; Wassim Kassouf; Armen G Aprikian
Journal:  World J Surg Oncol       Date:  2010-11-09       Impact factor: 2.754

8.  Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.

Authors:  Ashraf A Mosharafa; Richard S Foster; Michael O Koch; Richard Bihrle; John P Donohue
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

9.  Complications of post-chemotherapy retroperitoneal lymph node dissection.

Authors:  J Baniel; R S Foster; R G Rowland; R Bihrle; J P Donohue
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

10.  Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation.

Authors:  J P Donohue; J A Thornhill; R S Foster; R G Rowland; R Bihrle
Journal:  J Urol       Date:  1993-02       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.